Multicenter evaluation of commercial frozen plates for microdilution broth antifungal susceptibility testing of yeasts and comparison of MIC limits recommended in NCCLS M27-A2

Microbiology and Immunology

Volumn 49, Issue 2, 2005, Pages 97-106

  Makimura, Koichi ^a,g   Oguri, Toyoko ^b,g   Mikami, Yuzuru ^c,g   Kume, Hikaru ^d,g   Hanazawa, Ryo ^a   Abe, Michiko ^e   Ikeda, Reiko ^f   Shinoda, Takako ^f,g  

^a TEIKYO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY HOSPITAL   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KITASATO UNIVERSITY   (Japan)

^f MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^g Working Grp Antifungal S T   (Japan)

Author keywords

Broth microdilution antifungal susceptibility testing for yeast; Commercial frozen plate; MIC; Multicenter evaluation

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLINICAL LABORATORY; COMPARATIVE STUDY; CONTROLLED STUDY; MEDICAL SOCIETY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RELIABILITY; STANDARD;

CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; ISSATCHENKIA ORIENTALIS;

EID: 14944344609     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2005.tb03707.x     Document Type: Article

References (12)

1. Makimura, K., Sudo, T., Kudo, M., Uchida, K., and Yamaguchi, H. 1998. Development of reference procedures for broth microdilution antifungal susceptibility testing of yeasts with standardized endpoint determination. Microbiol. Immunol. 42: 55-59.
2. Makimura, K., Suzuki, T., Tamura, T., Ikedo, M., Hanazawa, R., Takahashi, Y., Yamada, Y., Uchida, K., and Yamaguchi, H. 2004. Comparative evaluation of standardized method of the Japanese Society for Medical Mycology and commercial frozen plate for microdilution broth antifungal susceptibility testing of yeasts with 200 clinical isolates. Microbiol. Immunol. 48: 747-753.
3. Matar, M.J., Ostrosky-Zeichner, L., Paetznick, V.L., Rodriguez, J.R., Chen, E., and Rex, J.H. 2003. Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob. Agents Chemother. 47: 1647-1651.
4. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M27-P, National Committee for Clinical Standards, Villanova, Pa.
5. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. Second edition, document M27-A2, National Committee for Clinical Laboratory Standards, Wayne, Pa.
6. Pfaller, M.A., Arikan, S., Lozano-Chiu, M., Chen, Y., Coffman, S., Messer, S.A., Rennie, R., Sand, C., Heffner, T., Rex, J.H., Wang, J., and Yamane, N. 1998. Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing. J. Clin. Microbiol. 36: 2609-2612.
7. Pfaller, M.A., Diekema, D.J., Messer, S.A., Boyken, L., Hollis, R.J., Jones, R.N., and the International Fungal Surveillance Participant Group. 2003. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J. Clin. Microbiol. 41: 78-83.
8. Rex, J.H., Pfaller, M.A., Barry, A.L., Nelson, P.W., and Webb, C.D. 1995. Antifungal susceptibility testing of isolates from randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob. Agents Chemother. 39: 40-44.
9. Shinoda, T., Makimura, K., Oguri, T., Mikami, Y., Kume, H., Matsumoto, T., Mochizuki, T., Ikeda, R., Mon, T., and Nakajima, H. 2002. Report of the Standardization Committee of the Japanese Society for Medical Mycology 1998-2000. Nippon Ishinkin Gakkai Zasshi 43: 107-123.
10. Sudo, T., Makimura, K., Kawada, K., Ito, A., Oka, S., Uchida, K., and Yamaguchi, H. 1997. Evaluation of anti-fungal susceptibility testing by the broth microdilution method against Candida species: activities of 5 antifungal agents Candida species isolated from oral candidiasis or other candidal infections and correlation of vitro data and clinical outcome of fluconazole therapy. Jpn. J. Chemother. 45: 115-122.
11. Takakura, S., Fujihara, N., Saito, T., Kudo, T., Iinuma, Y., and Ichiyama, S. 2003. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J. Antimicrob. Chemother. 53: 283-289.
12. Yamaguchi, H., Uchida, K., Kume, H., Shinoda, T., Watanabe, K., Kusunoki, T., Hiruma, M., and Ishizaki, H. 1995. Report of the Committee of Clinical Laboratory Standards -1994. Nippon Ishinkin Gakkai Zasshi 36: 61-86.